Apigenin has been reported to exert angiogenic and anticancer activities in vitro. The mechanism of inhibition of angiogenesis by apigenin, however, has not been well-established. In this study, we investigated whether apigenin not only inhibited tube formation but also induced apoptosis in human umbilical vein endothelial cells (HUVECs). Furthermore, strong antiangiogenic activity of apigenin was observed in the in vivo assay using chick embryo chorioallantoic membrane (CAM). We also analyzed changes in survival signals and the apoptotic pathway through Western blotting. The results indicate that apigenin exerts its antiangiogenic effects through induction of endothelial apoptosis.
Apigenin, a naturally occurring plant flavonoids, is mainly found in vegetables, fruits, and beverages derived from plants such as onion, parsley, orange, wheat sprouts, and tea [1] . It has been reported to possess various biological properties such as antioxidant, anticarcinogenic, and anti-inflammatory activities [2] [3] [4] . Studies have shown that apigenin possesses growth inhibitory effects against many human cancer cells, including breast, colon, skin, lung, thyroid, liver, pancreas, and solid malignant tumor cells [5] [6] [7] . Furthermore, the bioavailability of flavonoids has been evaluated consistently during recent years [8] [9] [10] [11] [12] [13] . However, there have been a limited number of reports concerning the antiangiogenic effects of apigenin and only a few reports on the effects of apigenin on angiogenesis at the molecular level.
Angiogenesis, or new blood vessel growth, is defined as a process in which a network of new blood vessels emerges from preexisting vessels and, as such, is essential for tumor growth and metastasis. Tumor angiogenesis can be a very effective target in cancer prevention and treatment [14] . In addition, the induction of apoptosis in endothelial cells is one of the major antiangiogenic mechanisms employed by angiogenesis inhibitors [15] . Healthpromoting food factors capable of inducing selective apoptosis only in cancer cells are receiving significant attention in the development of new approaches to cancer prevention. Many natural substances used in cancer chemotherapy have apoptosis-inducing activities [16] [17] [18] . Therefore, the anticancer activities of these substances are considered to be attributable to such apoptosis induction properties.
In this study, we examined the effects of apigenin on angiogesis in vitro through the inhibition of tube formation in endothelial cells. We also used the chick embryo chorioallantoic membrane (CAM) assay system to evaluate the in vivo angiogenic activity of apigenin. Furthermore, to clarify the mechanism of angiogenesis inhibition by apigenin, apigenin-induced changes in HUVECs were examined at the molecular level. We investigated whether apigenin-induced angiogenesis inhibition involved apoptosis or not and analyzed changes in survival signals as well as in the apoptotic pathway using Western blotting. To our knowledge, this is the first report that describes the antiangiogenic activity of apigenin using an in vivo model.
We first investigated the effect of apigenin on the early stages of capillary tube formation using an in vitro tube formation model involving HUVECs cultured in a two-dimensional system. Apigenin showed varying degrees of inhibitory effects on tube formation in endothelial cells in a concentration-dependent manner ( Figure 1A ). It slightly reduced the width of the tubes at 3.13 µg/mL, further reduced the width of the tubes and caused fragmentation of the network at 12.5 µg/mL and completely inhibited elongation of the cells at 50 µg/mL.
To evaluate the effects of apigenin on angiogenesis in vivo, we performed a chick CAM assay. Retinoic acid (5 nmol/egg) was used as a positive control. Apigenin (10-200 nmol/egg) significantly inhibited new blood vessel growth of chick embryos and suppressed embryonic angiogenesis in a dose-dependent manner ( Figure 1B) . Angiogenesis rates were 66.5% for retinoic acid and 40.4%, 59.7%, and 65.9% for apigenin (10, 50, and 200 nmol/egg), respectively, compared with the negative control. At a concentration of 200 nmol/egg, apigenin showed relatively similar antiangiogenic effects as those of retinoic acid.
We then observed the morphology of the cell nuclei to determine whether the cell death induced by apigenin was apoptosis. Apigenin induced apoptosis in a concentration-dependent manner (Figure 2A ). The rates for apoptotic cells were 23.4%, 30.4%, 37.9% and 47.2% for control and apigenin (3.13, 12.5, and 50 µg/mL) respectively, which were calculated to be a 1.3-, 1.6-and 2.0-fold increase for apigenin (3.13, 12.5, and 50 µg/mL) as compared with the control ( Figure 2B ). It was thus confirmed that apigenin caused cell death by inducing apoptosis in tube-forming HUVECs. We further analyzed how two major survival signals, ERK 1/2 and Akt, were affected by apigenin using Western blotting. Apigenin was shown to inactivate ERK 1/2 in a concentration-dependent manner ( Figure  2C changes compared with ERK 1/2. Therefore, the apigenin-induced inhibition of angiogenesis may be primarily due to blockade of the ERK signaling pathway.
To confirm the induction of apoptosis by apigenin in endothelial cells, HUVECs were treated with apigenin at various concentrations for different time periods (12 and 24 h), and changes in the activation state of caspase-3 were evaluated. As shown in Figure  3A , treatment of HUVECs with apigenin at concentrations of 0-50 µg/mL for 12 and 24 h significantly induced the activation of caspase-3 in a time-and concentration-dependent manner. These results confirmed that the activation of caspase-3 by apigenin may be involved in the induction of apoptosis in HUVECs. Apigenin also induced cleaved forms of the caspase substrates, poly ADPribose polymerase (PARP) and lamin A/C, in a concentration-
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Natural Product Communications Vol. 11 (10) 2016 1435 dependent manner. These results indicated that apigenin can induce apoptosis in HUVECs through the activation of caspase-3, and cleavage of PARP and lamin A/C. To acquire further clues about the inhibitory mechanisms, we next examined whether apigenin modulates the protein levels of angiogenesis-related cell adhesion molecules. There were significant concentration-dependent decreases in vascular endothelial cadherin (VE-cadherin) and platelet endothelial cell adhesion molecule-1 (PECAM-1) protein levels after apigenin treatment (0-50 µg/mL) ( Figure 3B ). In this study, we confirmed that apigenin possess antiangiogenic activities based on in vitro and in vivo angiogenesis models. We also found that apigenin suppresses angiogenesis, possibly through the induction of apoptosis in tube-forming endothelial cells. The results obtained from this study indicate that apigenin is a potent apoptosis-inducing agent; its action was accompanied by the activation of caspase-3, and cleavage of PARP and lamin A/C. Furthermore, the inhibitory effect of apigenin on tube formation appeared to be mediated by the inactivation of the ERK 1/2 survival signal. Such effects strongly support the possibility that we can improve health and prevent human cancers by daily intake of apigenin.
Experimental
Cell culture and materials: Apigenin was purchased from Sigma (St. Louis, MO, USA). HUVECs were isolated from human umbilical cord and were cultured as previously reported [19] . Briefly, cells were grown in MCDB-104 medium (Nihon Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with 10 ng/mL epidermal growth factor (EGF) (BD Biosciences, Bedford, MA, USA), 100 µg/mL heparin, 100 ng/mL endothelial cell growth factor (ECGF), and 10% fetal bovine serum (FBS) (Moregate, Brisbane, Australia). Medium 199 and all other chemicals were purchased from Sigma (St. Louis, MO, USA), unless otherwise noted. All antibodies used in this experiment were from Cell signaling Technology (Beverly, MA, USA). Fertilized chicken eggs were obtained from Pulmuone Farm (Danyang, Korea). Fat emulsion (20%) was from Green Cross Pharmacy Co. (Seoul, Korea).
Tube formation assay:
Capillary tube-like structures formed by HUVECs were prepared as previously described with slight modifications [2, 19] . Briefly, HUVECs (6.0 × 10 4 cells/cm 2 ) were seeded between two layers of collagen gel and then incubated in MCDB-104 medium with 0.5% FBS supplemented with 10 ng/mL of basic fibroblast growth factor, 8 nM phorbol 12-myristate 13acetate, and 25 µg/mL ascorbic acid. They were treated with various concentrations of apigenin (3.13, 12.5 , and 50 µg/mL) for up to 24 h. For Western blot analysis, cells (2.4 × 10 5 cells/48-well plate) were suspended three-dimensionally in collagen gel for 6, 12, 24, and 36 h.
CAM assay:
The CAM assay was performed as described previously with slight modifications [20, 21] . Briefly, fertilized chicken eggs were kept in a humidified incubator at 37°C. After 5 days of incubation, approximately 4 mL of albumin was aspirated from the eggs with an 18 gauge hypodermic needle through a small hole drilled at the narrow end of the eggs, allowing the small CAM and yolk sac to drop away from the shell membrane. Onto 6-day-old fertilized chicken embryos in the shells, 10 µL aliquots of either apigenin (10, 50, and 200 nmol/egg) or retinoic acid (5 nmol/egg), as a positive control, mixed in 1% methylcellulose, were applied in 2 mm silicon rings placed on the surface of the growing CAM. After 2 days of incubation, an appropriate volume of a 20% fat emulsion was injected into the CAM to visualize the blood vessels. At least 15 eggs were used for each condition, and experiments were repeated 5 times. The results were expressed as a suppression ratio of new vessels within the area encircled by a white ring.
Apoptosis:
The observation and quantification of apoptosis were carried out as previously described [22] . Briefly, fixed cells were stained with 500 ng/mL of 4',6-diamidino-2-phenylindole (DAPI). Cells exhibiting chromatin condensation and/or nuclear fragmentation were counted as apoptotic cells. A total of more than 500 cells from 6 fields were counted for each treatment.
Western blot analysis:
Western blotting was performed as previously described [22] . In brief, the cellular proteins from tubeforming HUVECs in the 3-D culture model were separated in a 6-12% SDS-polyacrylamide gel and then transferred to a Hybond-ECL nitrocellulose membrane (GE Healthcare, Chalfont St. Giles, UK). Immunoreactive protein bands were visualized using an ECL or ECL plus detection system (GE Healthcare). The values were obtained from at least 3 independent experiments. The membranes were also probed with β-actin to normalize the differences between the samples.
Statistical analysis:
Results are presented as the mean ± SE obtained from 3 or 5 independent experiments. Differences were ascertained by analysis of variance (ANOVA). Control and treatment outcomes were compared using Student's unpaired t-test (*P < 0.005, **P < 0.001).
